OrbiMed raises $4.3 bn for seed, growth bets
Mint Mumbai|October 26, 2023
Corpus to invest in healthcare, life sciences companies worldwide
Aman Rawat
OrbiMed raises $4.3 bn for seed, growth bets

Healthcare-focussed private equity firm OrbiMed, a backer of reproductive diagnostic solutions provider LifeCell and ayurvedic products brand Kapiva, has raised $4.3 billion to invest in healthcare and life sciences companies.

OrbiMed has raised the total corpus across three separate funds-OrbiMed Private Investments IX, OrbiMed Asia Partners V and OrbiMed Royalty & Credit Opportunities IV.

Investors in these new funds include a broad range of medical institutions, university endowments, foundations, pension funds, sovereign wealth funds and family offices, OrbiMed said in a statement.

"OrbiMed is deeply appreciative of the continued support we've received from many long-standing partners who've invested in these funds," said Carter Neild, managing partner at OrbiMed.

Bu hikaye Mint Mumbai dergisinin October 26, 2023 sayısından alınmıştır.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

Bu hikaye Mint Mumbai dergisinin October 26, 2023 sayısından alınmıştır.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

MINT MUMBAI DERGISINDEN DAHA FAZLA HIKAYETümünü görüntüle
Reduction of energy costs in the telecom sector
Mint Mumbai

Reduction of energy costs in the telecom sector

With telecom infrastructure companies looking for newer ways to cut back on energy costs, battery restoration technology provides telecom infrastructure firms with a viable, economical and green solution for uninterrupted power supply

time-read
5 dak  |
November 15, 2024
Skip cheese and sip wine in Switzerland
Mint Mumbai

Skip cheese and sip wine in Switzerland

Beyond chocolates and cheese, there's another Swiss gem to discover — vineyards that have been passed down through the generations

time-read
4 dak  |
November 15, 2024
Mint Mumbai

Bankers aren't always frank about bank regulation

The 'world's banker' Jamie Dimon, CEO of JPMorgan Chase, speaks his mind even if it means taking swipes at US regulators.

time-read
4 dak  |
November 15, 2024
Baku: A climate breakthrough looks depressingly bleak today
Mint Mumbai

Baku: A climate breakthrough looks depressingly bleak today

The success of fossil fuel-favouring politics threatens the planet

time-read
3 dak  |
November 15, 2024
Global solidarity levies can play a vital role in our climate efforts
Mint Mumbai

Global solidarity levies can play a vital role in our climate efforts

Solidarity taxes could support redistributive measures and optimize how we collectively tackle a great challenge of our times

time-read
3 dak  |
November 15, 2024
Speak for the Earth: It's the least we should do
Mint Mumbai

Speak for the Earth: It's the least we should do

This year's Booker prize winner turns our gaze to the planet from orbit and reminds us of the climate disaster that looms. Can odes sung to Earth move the world to act in its defence?

time-read
3 dak  |
November 15, 2024
Mint Mumbai

Aim for an efficient carbon market right from the start

India's economy is projected to grow dramatically over the next few decades. In nominal terms, it may double in size by 2030. This is exciting, but it comes with a significant risk.

time-read
3 dak  |
November 15, 2024
Mint Mumbai

Why health insurers refuse to cover certain treatments

While 12 modern treatments are covered, many advanced procedures are yet to be included

time-read
3 dak  |
November 15, 2024
Mint Mumbai

Address economic distress with structural reforms and not doles

Cash transfers may offer short-term relief but raising worker incomes is the only lasting solution

time-read
3 dak  |
November 15, 2024
Mint Mumbai

FUNDING FOREIGN EDUCATION: SHOULD YOU SAVE OR BORROW?

Education financing needs vary, but early planning is key to building your desired corpus

time-read
2 dak  |
November 15, 2024